Literature DB >> 29619662

Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.

Liang Tang1, Dong Wang1, Dongyun Gu2,3,4.   

Abstract

Osteosarcoma (OS) was a prevalent malignant bone tumor which threatens people's health worldwide. Wnt/β catenin signaling pathway had been proved significant in various cancers, indicating its possible function in OS as well. Sox2, a crucial member among SOX family could regulate cells biologically. How Sox2 modulated Wnt/β catenin signaling pathway in OS remained to be discussed. The study aimed to investigate the effects of Sox2 on the invasion and migration of OS cells and the related molecular mechanisms. Twenty-four human OS and adjacent tissue samples were involved in this study. Human OS cell lines MG63 and HOS were selected for further investigation. The liposome carrier si-Sox2 which could interfere with the expression of Sox2 gene was built to transfect MG63 and HOS cells). QRT-PCR assay and western blot were utilized to analyze the expression of mRNA and proteins of Sox2. Transwell assay and wound healing assay were conducted to test the invasion and migration level of cells. The expression of GSK3, β-catenin, cyclin D1 and c-myc proteins were detected by western blot assay after transfection with si-Sox2. Compared with normal tissues and cells, the expression of Sox2 in OS tissues and cells was significantly higher. The mRNA and protein levels of Sox2 significantly decreased after transfection with si-Sox2. The invasion and migration of OS cells were down-regulated significantly through the inhibition of Sox2 by inactivating Wnt/β-catenin signaling pathway related proteins. Knockdown of Sox2 could inhibit invasion and migration of OS cells via modulating Wnt/β-catenin signaling pathway.

Entities:  

Keywords:  Osteosarcoma; Sox2; Wnt/β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29619662     DOI: 10.1007/s12253-018-0400-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

1.  Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.

Authors:  Xun-Bing Zhu; Zhong-Chuan Zhang; Guan-Sheng Han; Jun-Zhu Han; Da-Peng Qiu
Journal:  Mol Med Rep       Date:  2017-02-14       Impact factor: 2.952

Review 2.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

Review 3.  The cross-regulation between SOX15 and Wnt signaling pathway.

Authors:  Ali Moradi; Faezeh Ghasemi; Kazem Anvari; Seyed Mahdi Hassanian; Saeideh Ahmadi Simab; Safieh Ebrahimi; Amirreza Hesari; Mohammad Mahdi Forghanifard; Mohammad Taher Boroushaki; Soodabeh ShahidSales; Amir Avan
Journal:  J Cell Physiol       Date:  2017-03-27       Impact factor: 6.384

4.  SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.

Authors:  Thomas Hussenet; Stanislas du Manoir
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

Review 5.  Regulation of bone mass by Wnt signaling.

Authors:  Venkatesh Krishnan; Henry U Bryant; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 6.  The Roles of Sox Family Genes in Sarcoma.

Authors:  Jingyuan Li; Jacson Shen; Kunzheng Wang; Francis Hornicek; Zhenfeng Duan
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

7.  Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

Authors:  Alexander J Chou; Eugenie S Kleinerman; Mark D Krailo; Zhengjia Chen; Donna L Betcher; John H Healey; Ernest U Conrad; Michael L Nieder; Michael A Weiner; Robert J Wells; Richard B Womer; Paul A Meyers
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

8.  Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.

Authors:  Huancai Liu; Yanchun Chen; Fenghua Zhou; Linlin Jie; Leidong Pu; Jie Ju; Fengjie Li; Zhigang Dai; Xin Wang; Shuanhu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.

Authors:  Alka Mansukhani; Davide Ambrosetti; Greg Holmes; Lizbeth Cornivelli; Claudio Basilico
Journal:  J Cell Biol       Date:  2005-03-21       Impact factor: 10.539

10.  miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.

Authors:  Chenglin Yang; Chunying Hou; Hepeng Zhang; Dewei Wang; Yan Ma; Yunqi Zhang; Xiaoyan Xu; Zhenggang Bi; Shuo Geng
Journal:  Int J Mol Sci       Date:  2013-12-31       Impact factor: 5.923

View more
  3 in total

1.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

2.  MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1.

Authors:  Weichao Li; Zengdong Meng; Tiannan Zou; Gang Wang; Yijing Su; Shaoping Yao; Xianrun Sun
Journal:  Pathol Oncol Res       Date:  2018-12-06       Impact factor: 3.201

3.  Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma.

Authors:  Chao He; Chao Liu; Lei Wang; Yangbai Sun; Yuhang Jiang; Yongqiang Hao
Journal:  Cell Death Dis       Date:  2019-01-25       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.